Clinical Trial Update: Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of the investigational drug HS-10375 for advanced or metastatic non-small cell lung cancer, which is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HS-10375 (HS-10375)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Advanced or Metastatic NSCLC | Phase 1, Phase 2 | Status: RECRUITING